Advertisement
Loading...

Dr. Reddy's Laboratories Limited

RDY•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$13.61
$0.12(0.89%)
U.S. Market opens in 28h 23m

Dr. Reddy's Laboratories Limited (RDY) Stock Overview

Explore Dr. Reddy's Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.3B
P/E Ratio25.43
EPS (TTM)$0.53
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$14.53
3 Months$15.61
1 Year Target$13.53

RDY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dr. Reddy's Laboratories Limited (RDY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.43 and a market capitalization of 11.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.89%
5-Day Change
0.37%
1-Month Change
5.18%
3-Month Change
-3.75%
6-Month Change
-2.37%
Year-to-Date (YTD) Change
-3.06%
1-Year Change
-5.42%
3-Year Change
23.06%
5-Year Change
-5.49%
All-Time (Max) Change
1247.52%

Contact Information

https://www.drreddys.com
91 40 4900 2900
8-2-337, Road No. 3, Hyderabad, NaN, 500034

Company Facts

27,048 Employees
IPO DateApr 11, 2001
CountryIN
Actively Trading

Frequently Asked Questions